NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri

CME Course Description

Login to view
Course Activities.

National Association For Continuing Education

Course Directors
Gregg Sherman, MD
Chief Medical Officer, NACE
Plantation, FL

Deborah Paschal, CRNP
Philadelphia, PA

Medical Writer
Josh Kilbridge
Kilbride Associates Healthcare Communications
San Francisco, CA

Course Reviewer
Alanna A. Morris, MD
Assistant Professor, Advanced Heart Failure/Transplant
Emory University School of Medicine
Director of Heart Failure Services
Atlanta VA Medical Center
Atlanta, GA

Registration for this expired course is open for zero credits.

Recognizing Phenotypes and Evidence-Based Treatments in the Management of Heart Failure
Activity/Course #:

Release/Start Date:
Dec 15 2017
Expiration Date:
Dec 14 2018
Target Audience:
Primary Care Providers
Estimated Time To Complete CME Activity:
1.0 Hour
Hardware/Software Requirements:
Internet Explorer, Firefox and Safari browsers (Chrome not supported at this time)
This monograph reviews Heart failure (HF). Heart failure (HF) is a complex and deadly condition that affects millions of Americans and costs billions of dollars to manage. Primary care clinicians contribute to the efficient management of HF in important ways. Patients with or at risk for HF typically present first in primary care settings, and clinicians must recognize the risk factors and features of HF to initiate appropriate diagnostic and assessment pathways. Once diagnosed, successful management of HF depends on the appropriate use of guideline-directed medical therapy (GDMT), frequent follow up and monitoring, and ongoing patient education. Patients with HF who are not well managed in the outpatient setting have high hospitalization rates, contributing to increased costs and risk for mortality. This monograph reviews the latest data on the recognition and management of HF, with a focus on the tailoring of therapy for specific racial and ethnic groups.

Learning Objective(s):

After completing this program participants should be able to:

  1. Recognize the different phenotypic presentations of HF
  2. Identify predictors of poor outcomes in HF
  3. Discuss the role of new therapies in the management of chronic HF according to the latest ACC/AHA/HFSA/ADA guidelines
  4. Recognize strategies to reduce hospitalization for HF

How To Obtain Your CME Certificate

  1. Register for the course at
  2. Complete the pre-test.
  3. View the content.
  4. Complete and submit the post-test and evaluation.
  5. A minimum passing score of 70% must be earned on the post-test in order to complete the CME activity.
  6. Print your CME certificate.
Sponsored and Certified By
National Association for Continuing Education & Association of Black Cardiologists, Inc.
Accreditation Designation Statement
The Association of Black Cardiologists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Association of Black Cardiologists designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1.0 contact hour of continuing education(which includes 0.75 pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosures are provided below.

Alanna A. Morris, MD, Course Reviewer, serves as a consultant for Novartis Pharmceuticals Corporation.

Gregg Sherman, MD, Co-Course Director, has no relationships to disclose.

Deborah Paschal, CRNP, Co-Course Director, has no relationships to disclose.

Josh Kilbridge, Medical Writer, has no relationships to disclose.

Harvey C. Parker, Ph.D., Activity Planning Committee, has no relationships to disclose.

Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.

Cassandra A. McCullough, MBA, Activity Planning Committee, has no relationships to disclose.
Commercial Support
This activity is supported by educational funding provided by Amgen and an educational grant from Novartis Pharmaceuticals Corporation.